The Canadian Nuclear Safety Commission (CNSC) is announcing the location of the public hearing to consider the application from BWXT Nuclear Energy Canada Inc. and also the extension to the deadline for filing requests to intervene.
The regulatory document does not contain new requirements. The revision reflects administrative changes, which were made to align existing content with the CNSC’s updated naming convention and format for regulatory documents
REGDOC-3.3.1, Financial Guarantees for Decommissioning of Nuclear Facilities and Termination of Licensed Activities, sets out requirements and guidance for the establishment and maintenance of funding for the decommissioning of facilities and termination of activities.
REGDOC-2.11.2, Decommissioning, sets out requirements and guidance for planning, preparation, execution and completion of decommissioning activities associated with nuclear power plants, uranium mines and mills, and waste nuclear substance activities licensed by the CNSC in Canada.
CNSC inspection identifies instances of non-compliance with regulatory requirements related to worker training, dose ascertainment, device labelling, radiation protection equipment, and transportation of nuclear gauges.
The company was not complying with a licence condition with respect to procedures for entering vessels fitted with radiation devices. The inspection also identified instances of non-compliance related to worker training and the ascertainment of doses to workers entering vessels fitted with radiation devices.
Worker failed to comply with company procedures and regulatory requirements when operating a portable nuclear gauge, and failed to ensure the security of the portable nuclear gauge used at the work site.
Participant funding is currently available for the December 11–12, 2019, public meeting where CNSC staff will present their Regulatory Oversight Report for Uranium and Nuclear Substance Processing Facilities in Canada: 2018
This report focuses on the results of compliance verification and enforcement activities in 2017 for licensees in the medical, industrial, academic and research, commercial, and waste nuclear substances sectors.
Failure to comply with regulatory requirements for management oversight of the radiation protection program, and for worker training, prescribed records, ascertainment of doses and transportation of nuclear gauges
Am I safe? This short question is often difficult to answer for public communicators during a nuclear or radiological emergency.
The report details expert-level discussions that were held on addressing this and other communication challenges.
Participant funding is currently available for the November 6-7, 2019 meeting to assist Indigenous peoples, members of the public, and stakeholders in reviewing the Regulatory Oversight Report for Canadian Nuclear Power Generating Sites: 2018 and the Regulatory Oversight Report on the Use of Nuclear Substances in Canada: 2018, and submitting comments to the Commission.
The CNSC received no feedback on comments for REGDOC-3.1.3, Reporting Requirements for Waste Nuclear Substance Licensees, Class II Nuclear Facilities and Users of Prescribed Equipment, Nuclear Substances and Radiation Devices.
Licensee must cease all use of its portable devices until it can demonstrate an effective management oversight of its radiation protection program and that all previous non-compliances have been corrected.
Participant funding is currently available for Canadian Nuclear Laboratories Ltd.’s Near Surface Disposal Facility project, the In Situ decommissioning of the Whiteshell Reactor-1 project and the Nuclear Power Demonstration Closure project.
Participant funding is currently available for the October 2–3, 2019 meeting to assist Indigenous peoples, members of the public, and stakeholders in reviewing the Regulatory Oversight Report for Canadian Nuclear Laboratories Sites: 2018 and submitting comments to the Commission.
Participant funding is currently available for the October 2–3, 2019 hearing to consider the licence renewal for nuclear research and test establishment decommissioning licence for the Whiteshell Laboratories site